National Centre for Clinical Research on Emerging Drugs (NCCRED) - Bringing researchers and clinicians together: a highlight on methamphetamine
Presenter: Nadine Ezard
Author names: Prof Nadine Ezard
Author affiliations: Director, National Centre for Clinical Research on Emerging Drugs
Clinical Director of the Alcohol and Drug Service at St Vincent’s Hospital
The National Centre for Clinical Research on Emerging Drugs (NCCRED) represents a new direction for the Australian AOD sector. Since its formation in 2017 as part of the National Ice Action Strategy, NCCRED has built clinical research capacity and supported new directions in evidence based clinical treatment within the Australian alcohol and other drugs (AOD) services sector, with an emphasis on responses to people who use methamphetamine and emerging drugs of concern.
The Centre has a strategic approach that encompasses three key areas of activity at a national level: 1) collaborate by engaging with key stakeholders to build adaptive clinical networks that build capacity for clinical research opportunities into emerging drugs that have prevalent, persistent and harmful health and community impacts; 2) generate new evidence for effective interventions directed towards identified research priorities by way of collaborative clinical research, seed funding and scholarships; and 3) translate, implement and disseminate these evidence-based interventions through networks, to further develop and equip the health and medical research workforce.
With a focus on methamphetamine, the session will outline NCCRED’s clinical research priorities, achievements and directions; its significant capacity building steps in developing national clinical research into innovative treatments and responses to methamphetamine; and its development of key national clinical networks.
